{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T22:24:32Z","timestamp":1794349472170,"version":"4.9.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.eclinm.2025.103599","type":"journal-article","created":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T05:31:19Z","timestamp":1761370279000},"page":"103599","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Less is more: inverting the paradigm across the cancer care continuum"],"prefix":"10.1016","volume":"90","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3383-8171","authenticated-orcid":false,"given":"Julien A.M.","family":"Vos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1239-9867","authenticated-orcid":false,"given":"Sahar","family":"Barjesteh van Waalwijk van Doorn-Khosrovani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans M.","family":"Westgeest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.eclinm.2025.103599_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"16","key":"10.1016\/j.eclinm.2025.103599_bib2","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1056\/NEJMp2109826","article-title":"The drug-dosing conundrum in oncology \u2014 when less is more","volume":"385","author":"Shah","year":"2021","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103599_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2024.104099","article-title":"A taxonomy of the factors contributing to the overtreatment of cancer patients at the end of life. What is the problem? Why does it happen? How can it be addressed?","volume":"10","author":"Cherny","year":"2025","journal-title":"ESMO Open"},{"issue":"5","key":"10.1016\/j.eclinm.2025.103599_bib4","doi-asserted-by":"crossref","first-page":"e250746","DOI":"10.1001\/jamahealthforum.2025.0746","article-title":"Global adoption of value-based health care initiatives within health systems: a scoping review","volume":"6","author":"Douglas","year":"2025","journal-title":"JAMA Health Forum"},{"issue":"10","key":"10.1016\/j.eclinm.2025.103599_bib5","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1200\/OP.22.00130","article-title":"Implementation and impact of choosing wisely recommendations in oncology","volume":"18","author":"Nagarajah","year":"2022","journal-title":"JCO Oncol Pract"},{"key":"10.1016\/j.eclinm.2025.103599_bib7","article-title":"Effectiveness of and overdiagnosis from mammography screening in the Netherlands: population based study","volume":"359","author":"Autier","year":"2017","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.eclinm.2025.103599_bib9","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1056\/NEJMoa1911793","article-title":"Reduced lung-cancer mortality with volume CT screening in a randomized trial","volume":"382","author":"de Koning","year":"2020","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.eclinm.2025.103599_bib10","first-page":"405","article-title":"Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States, 2019","volume":"74","author":"Islami","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"8","key":"10.1016\/j.eclinm.2025.103599_bib12","doi-asserted-by":"crossref","first-page":"e340","DOI":"10.1016\/S1470-2045(24)00134-7","article-title":"Dose selection of novel anticancer drugs: exposing the gap between selected and required doses","volume":"25","author":"Hoog","year":"2024","journal-title":"Lancet Oncol"},{"issue":"12","key":"10.1016\/j.eclinm.2025.103599_bib13","doi-asserted-by":"crossref","first-page":"e552","DOI":"10.1016\/S1470-2045(22)00554-X","article-title":"Alternative dosing strategies for immune checkpoint inhibitors to improve cost-effectiveness: a special focus on nivolumab and pembrolizumab","volume":"23","author":"Malmberg","year":"2022","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.eclinm.2025.103599_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2024.107950","article-title":"Real-world overall survival after alternative dosing for pembrolizumab in the treatment of non-small cell lung cancer: a nationwide retrospective cohort study with a non-inferiority primary objective","volume":"196","author":"Grit","year":"2024","journal-title":"Lung Cancer"},{"issue":"11","key":"10.1016\/j.eclinm.2025.103599_bib15","doi-asserted-by":"crossref","first-page":"e915","DOI":"10.1016\/S2542-5196(24)00245-6","article-title":"Effect of alternative dosing strategies of pembrolizumab and nivolumab on health-care emissions in the Netherlands: a carbon footprint analysis","volume":"8","author":"Malmberg","year":"2024","journal-title":"Lancet Planet Health"},{"key":"10.1016\/j.eclinm.2025.103599_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1274532","article-title":"Integrating treatment cost reduction strategies and biomarker research to reduce costs and personalize expensive treatments: an example of a self-funding trial in non-small cell lung cancer","volume":"14","author":"Buma","year":"2023","journal-title":"Front Pharmacol"},{"issue":"25","key":"10.1016\/j.eclinm.2025.103599_bib18","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1200\/JCO-25-00488","article-title":"Totality of the evidence: optimizing dosage selection strategies in oncology","volume":"43","author":"Levit","year":"2025","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.eclinm.2025.103599_bib19","doi-asserted-by":"crossref","first-page":"e282","DOI":"10.1016\/S1470-2045(25)00037-3","article-title":"Determining the optimal use of approved drugs in oncology","volume":"26","author":"Bouche","year":"2025","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.eclinm.2025.103599_bib20","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.ijrobp.2024.09.019","article-title":"Dose deintensified 3-Day photon, proton, or brachytherapy: a nonrandomized controlled partial breast irradiation trial","volume":"121","author":"Mutter","year":"2025","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"7","key":"10.1016\/j.eclinm.2025.103599_bib21","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1001\/jamaoncol.2025.1002","article-title":"Overall survival and quality-of-life superiority in modern phase 3 oncology trials: a meta-epidemiological analysis","volume":"11","author":"Sherry","year":"2025","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.eclinm.2025.103599_bib22","series-title":"Approaches to assessment of overall survival in oncology clinical trials","year":"2025"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103599_bib23","article-title":"A systematic review comparing surveillance recommendations for the detection of recurrence following surgery across 16 common cancer types","volume":"4","author":"Hannah","year":"2025","journal-title":"BMJ Oncol"},{"issue":"6","key":"10.1016\/j.eclinm.2025.103599_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2022.100600","article-title":"The meaning of screening: detection of brain metastasis in the adjuvant setting for stage III melanoma","volume":"7","author":"Derks","year":"2022","journal-title":"ESMO Open"},{"key":"10.1016\/j.eclinm.2025.103599_bib25","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ejca.2022.07.025","article-title":"Follow-up strategy and survival for five common cancers: a meta-analysis","volume":"174","author":"Galjart","year":"2022","journal-title":"Eur J Cancer"},{"issue":"10","key":"10.1016\/j.eclinm.2025.103599_bib26","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1093\/jnci\/djac131","article-title":"Surveillance imaging vs symptomatic recurrence detection and survival in stage II-III breast cancer (AFT-01)","volume":"114","author":"Schumacher","year":"2022","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"10.1016\/j.eclinm.2025.103599_bib27","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/bjs\/znad022","article-title":"Oncological surgery follow-up and quality of life: meta-analysis","volume":"110","author":"Wullaert","year":"2023","journal-title":"Br J Surg"},{"key":"10.1016\/j.eclinm.2025.103599_bib28","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ygyno.2024.06.020","article-title":"Effect of reduced follow-up care on patient satisfaction with care among patients with endometrial cancer: the ENSURE randomized controlled trial","volume":"188","author":"Ezendam","year":"2024","journal-title":"Gynecol Oncol"},{"issue":"5","key":"10.1016\/j.eclinm.2025.103599_bib30","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/imj.16325","article-title":"Patients' perception of the benefits of palliative systemic therapy for advanced cancer","volume":"54","author":"Subramaniam","year":"2024","journal-title":"Intern Med J"},{"issue":"12","key":"10.1016\/j.eclinm.2025.103599_bib31","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1089\/jpm.2020.0800","article-title":"High-intensity care in the end-of-life phase of castration-resistant prostate cancer patients: results from the Dutch CAPRI-registry","volume":"24","author":"Westgeest","year":"2021","journal-title":"J Palliat Med"},{"issue":"8042","key":"10.1016\/j.eclinm.2025.103599_bib32","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/s41586-024-08035-2","article-title":"Early versus deferred use of CDK4\/6 inhibitors in advanced breast cancer","volume":"636","author":"Sonke","year":"2024","journal-title":"Nature"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537025005322?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537025005322?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T21:34:54Z","timestamp":1794346494000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537025005322"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":27,"alternative-id":["S2589537025005322"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2025.103599","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Less is more: inverting the paradigm across the cancer care continuum","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2025.103599","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103599"}}